Last reviewed · How we verify
SN132D
At a glance
| Generic name | SN132D |
|---|---|
| Also known as | SpagoPix |
| Sponsor | Spago Nanomedical AB |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Efficacy of SN132D in Patients With Suspected Endometriosis (PHASE2)
- A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SN132D CI brief — competitive landscape report
- SN132D updates RSS · CI watch RSS
- Spago Nanomedical AB portfolio CI